The Therapeutic Goods Administration (TGA) have issued a reminder that Zostavax® vaccine should not be administered to people with compromised immune function. Vaccination in this patient group is contraindicated and can result in infection with the vaccine virus causing mild to severe complications (including death).

Further details on the alert can be seen here: TGA: Zostavax® vaccine

For more information on Zostavax® and access to the Zostavax® GP decision aid please review the MVEC pages below:

एमवीईसी: ज़ोस्टर
MVEC: Zoster vaccine (Zostavax®) FAQ’s